Clinical trial
Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial…
NCT00040729 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00040729 |
|---|---|
| Title | Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C |
| Official title | Retrospective Analysis Of Promoter Polymorphism Of UGT1A1 Gene In Cancer Patients Enrolled On Clinical Trials With Flavopiridol At National Cancer Institute To Assess The Pharmacokinetics And Pharmacodynamics Of Flavopiridol |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Genetic |
| Interventions | mutation analysis |
| Start date | Mar 1, 2002 |
| First posted | Jun 26, 2003 |
| Last update posted | Apr 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: